Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Fastly Inc FSLY

Fastly, Inc. provides a programmable edge cloud platform that helps the world’s brands deliver online experiences possible through edge compute, delivery, security, and observability offerings, improving site performance, and enhancing security at a global scale. The Company enables developers to deliver secure Websites and apps. The edge cloud is a category of Infrastructure as a Service (IaaS) that enables developers to build, secure, and deliver digital experiences at the edge of the Internet. Its network services are designed to speed up and optimize the delivery of Web and application traffic while ensuring developers and engineers do not lose visibility or control. The Company’s professional services include network services, managed security service, and response security service. The Company offers three levels of support plans and available technical support add-ons with dedicated technical specialists and account managers that provide extended security expertise.


NYSE:FSLY - Post by User

<< Previous
Bullboard Posts
Next >>
Post by Irene89on Apr 19, 2022 10:50pm
65 Views
Post# 34615325

FSD Pharma Inc: Lucid MS Video

FSD Pharma Inc: Lucid MS Video


FSD Pharma is delighted to announce pre-clinical findings indicating the efficacy of Lucid-MS, its flagship medication candidate, in treating Multiple Sclerosis. Lucid-MS's therapeutic potential is an industry first, and we'd like to provide visual evidence of functional recovery in pre-clinical individuals in this video!

<< Previous
Bullboard Posts
Next >>